CARDIOL RES PRACT 润色咨询

Cardiology Research and Practice

出版年份：暂无数据 年文章数：628 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：0.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1217308, encodeId=b1e2121e3082d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：临床药学<br>经验分享：2021年11月底投稿，一审1月18日回复小修，二审2月9日接受，支付版面费后3月7日见刊，整个过程非常快，适合急需文章申请职称的朋友。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9945679268, createdName=ms6000001488510329, createdTime=Fri May 06 11:07:55 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568872, encodeId=364b5688e254, content=1.92了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568324, encodeId=8ddc5683242f, content=实时1.72了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=)]
    2022-05-06 ms6000001488510329

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：临床药学
    经验分享：2021年11月底投稿，一审1月18日回复小修，二审2月9日接受，支付版面费后3月7日见刊，整个过程非常快，适合急需文章申请职称的朋友。

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1217308, encodeId=b1e2121e3082d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：临床药学<br>经验分享：2021年11月底投稿，一审1月18日回复小修，二审2月9日接受，支付版面费后3月7日见刊，整个过程非常快，适合急需文章申请职称的朋友。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9945679268, createdName=ms6000001488510329, createdTime=Fri May 06 11:07:55 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568872, encodeId=364b5688e254, content=1.92了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568324, encodeId=8ddc5683242f, content=实时1.72了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=)]
    2019-03-30 qqd140d1b8

    1.92了！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1217308, encodeId=b1e2121e3082d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：临床药学<br>经验分享：2021年11月底投稿，一审1月18日回复小修，二审2月9日接受，支付版面费后3月7日见刊，整个过程非常快，适合急需文章申请职称的朋友。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9945679268, createdName=ms6000001488510329, createdTime=Fri May 06 11:07:55 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568872, encodeId=364b5688e254, content=1.92了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Sat Mar 30 00:00:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568324, encodeId=8ddc5683242f, content=实时1.72了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Tue Mar 19 00:00:00 CST 2019, time=2019-03-19, status=1, ipAttribution=)]
    2019-03-19 qqd140d1b8

    实时1.72了

    0

共7条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分